Biochips Market to Reach $25.8 billion with 19.6% CAGR Forecast to 2022

PUNE, INDIA, July 22, 2016 /EINPresswire.com/ -- According to researcher, the Bio Chip Market accounted for $7.35 billion in 2015 and is expected to grow at a CAGR of 19.6% to reach $25.8 billion by 2022. Increasing number of applications in drug discovery euipments, high precision of diagnosis treatments, growing number of cancer treatments leads to the usage of personalized medicine and high advancements in technology are some of the factors driving the market growth. However, unclear guiding principles, lack of awareness of biochips among rural communities and high cost of products are the restraints hampering the market growth during the forecast period. Considerable growth prediction in emerging countries such as China and India act as a opportunity for the biochip market.

Complete report details @ https://www.wiseguyreports.com/reports/562673-biochips-global-market-outlook-2015-2022

DNA biochips segment is expected to witness the highest CAGR across the globe due to its growing applications in biotechnology and drug discovery. North America region is estimated to have largest share across globe, attributed to its factors such as growing aging population and growing incidence of diseases. On the other hand, Asia-Pacific is anticipated to grow at the highest CAGR over the forecast period.
Some of the key players in global Bio Chip market include Abbott Laboratories, Agilent TechnologiesInc., Perkinelmer, Inc., Fluidigm Corporation, Roche Diagnostics, Thermo Fisher Scientific Inc., Cepheid Inc., Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., Affymetrix Inc., Beckman Coulter Inc., Life Technologies Corp, Roche, Life Technologies Corp and Biomerieux SA.

Request a sample report @ https://www.wiseguyreports.com/sample-request/562673-biochips-global-market-outlook-2015-2022

Products Covered:
• Micro array
o Lab-On-A-Chip microarray
o Protein Microarray
o Other Protein Microarray
o DNA Microarray
o Other Microarray Types
o Tissue Biochips
o Carbohydrate Biochips
• Microfluidics
• Analysis Software
• Biochip instruments
• Biochip reagents
End Users Covered:
• Academic & Research Institute
• Biotechnology and Pharmaceutical Companies
• Hospitals and Diagnostics Centres
• Other End Users
Applications Covered:
• Diagnostic Applications
o Immune disease diagnostic
o Neurological diagnostic
o Cardiac diagnostic
o Other Applications
• Drug Discovery
o Structural Biology
o Lead Optimization
o Preclinical and Clinical Trial
o Process R&D
• Genomics
• Proteomics
• Other Applications
Functions Covered:
• Micro-RNA
• Gene Expression
• Epigenetic
• Genotyping
• Sequence Capture
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Make an enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/562673-biochips-global-market-outlook-2015-2022

Table of content
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Application Analysis
3.9 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global BioChips Market, By Product
5.1 Introduction
5.2 Microarray
5.2.1 Lab-On-A Chip Microarray
5.2.1.1 Drug Discovery
5.2.1.2 Genomics
5.2.1.3 Proteomics
5.2.1.4 Clinical Diagnostics
5.2.1.5 IVD & POC
5.2.1.6 Other Lab-On-A Chip Microarray
5.2.2 Protein Microarray
5.2.2.1 High-Throughput Screening
5.2.2.2 Expression Profiling
5.2.2.3 Drug Discovery
5.2.2.4 Diagnostics
5.2.2.5 Proteomics
5.2.2.6 Other Protein Microarray
5.2.3 DNA Microarray
5.2.3.1 Agricultural Biotechnology
5.2.3.2 Genomics
5.2.3.3 SNP Genotyping
5.2.3.4 Drug Discovery
5.2.3.5 Cancer Diagnosis & Treatment
5.2.3.6 Gene Expression
5.2.3.7 Other DNA Chip Applications
5.2.4 Other Microarray Types
5.2.4.1 Cell Arrays
5.2.4.2 Tissue Arrays
5.2.5 Tissue Biochips
5.2.6 Carbohydrate Biochips
5.3 Microfluidics
5.4 Analysis Software
5.5 Biochip instruments
5.6 Biochip reagents

6 Global BioChips Market, By End User
6.1 Introduction
6.2 Hospitals and Diagnostics Centers
6.3 Biotechnology and Pharmaceutical Companies
6.4 Academic & Research Institutes
6.5 Other End User

7 Global BioChips Market, By Application
7.1 Introduction
7.2 Diagnostic Applications
7.2.1 Immune disease diagnostic
7.2.2 Neurological diagnostic
7.2.3 Cardiac diagnostic
7.2.4 Other Applications
7.3 Drug Discovery
7.3.1 Structural Biology
7.3.2 Lead Optimization
7.3.3 Preclinical and Clinical Trial
7.3.4 Process R&D
7.4 Genomics
7.5 Proteomics
7.6 Other Applications

8 Global BioChips Market, By Function
8.1 Introduction
8.2 Micro-RNA
8.3 Gene Expression
8.4 Epigenetic
8.5 Genotyping
8.6 Sequence Capture

9 Global BioChips Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Abbott Laboratories
11.2 Agilent Technologies, Inc.
11.3 Perkinelmer, Inc.
11.4 Fluidigm Corporation
11.5 Roche Diagnostics
11.6 Thermo Fisher Scientific, Inc.
11.7 Cepheid Inc.
11.8 Bio-Rad Laboratories Inc.
11.9 GE Healthcare
11.10 Illumina, Inc.
11.11 Affymetrix Inc
11.12 Beckman Coulter Inc
11.13 Life Technologies Corp
11.14 Biomerieux SA

Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=562673

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here